Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.
16.06.2025 07:00:04

Leclanché Receives Lloyds Register and Bureau Veritas Type Approvals for Navius MRS-3 Marine Rack System

Leclanché SA / Key word(s): Product Launch
Leclanché Receives Lloyds Register and Bureau Veritas Type Approvals for Navius MRS-3 Marine Rack System

16.06.2025 / 07:00 CET/CEST


Leclanché Receives Lloyds Register and Bureau Veritas Type Approvals for Navius MRS-3 Marine Rack System

  •  Lloyd’sRegister (LR) and Bureau Veritas (BV) certify that NaviusMRS3 meets the industry’s highest safety and performance benchmarks
  • Type Approvals underscore Leclanché’s mission to deliver safe, highquality and environmentally sound energystorage solutions to the global maritime sector
  • Endorsement by two of the world’s most respected classification societies validates the system’s suitability for applications ranging from commercial shipping to luxury yachts

YVERDONLESBAINS, Switzerland, 16th June 2025Leclanché SA (SIX: LECN), a global leader in energy‑storage solutions, today announced that its Navius MRS‑3 marine rack system has been awarded  Type Approval certificates by Lloyd’s Register and Bureau Veritas.

The approvals certify that the lithium‑ion‑based NaviusMRS‑3 battery system complies with LR and BV’s rigorous design, safety and performance requirements for marine equipment. The modular system provides a flexible, high‑energy‑density solution that can be seamlessly integrated into a broad range of vessels, helping owners and operators decarbonise their fleets while meeting increasingly strict emissions regulations.

We are delighted to have received Type Approvals from two of the leading classification societies, Lloyd’s Register and Bureau Veritassaid Jean-Sébastien Weiss, Marine Certification Engineer at Leclanché. “This accomplishment underscores our focus on providing reliable, safe, and efficient energy storage solutions for the marine sector, and highlights the hard work and collaboration of our team and partners in meeting the demanding standards of the global maritime industry”.

Lloyd’sRegister and Bureau Veritas are globally recognised for setting and upholding maritime standards. Their independent validation of the NaviusMRS‑3 further reinforces Leclanché’s position as a trusted partner for shipyards, integrators and vessel owners seeking proven energy‑storage solutions.

# # #

 

 About Leclanché

Leclanché is a world leading provider of low-carbon footprint energy storage solutions based on lithium-ion cell technology. Established in 1909 in Yverdon-les-Bains, Switzerland, Leclanché’s history and heritage is rooted in battery and energy storage innovation. The company’s Swiss culture for precision and quality, together with its production facilities in Germany, make Leclanché the partner of choice for companies seeking the very best in battery performance and who are pioneering positive changes in how energy is produced, distributed and consumed around the world. Leclanché is organised into three business units: energy storage solutions, e-Mobility solutions and specialty battery systems. The company currently employs over 350 people with representative offices in eight countries around the world. Leclanché is listed on the Swiss Stock Exchange (SIX: LECN). SIX Swiss Exchange : ticker symbol LECN | ISIN CH 011 030 311 9

 

Disclaimer

This press release contains certain forward-looking statements relating to Leclanché's business, which can be identified by terminology such as "strategic", "proposes", "to introduce", "will", "planned", "expected", "commitment", "expects", "set", "preparing", "plans", "estimates", "aims", "would", "potential", "awaiting", "estimated", "proposal", or similar expressions, or by expressed or implied discussions regarding the ramp up of Leclanché's production capacity, potential applications for existing products, or regarding potential future revenues from any such products, or potential future sales or earnings of Leclanché or any of its business units. You should not place undue reliance on these statements. Such forward-looking statements reflect the current views of Leclanché regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that Leclanché's products will achieve any particular revenue levels. Nor can there be any guarantee that Leclanché, or any of the business units, will achieve any particular financial results.

 

Media contacts: 

Switzerland / Europe: 
Thierry Meyer
T: +41 (0) 79 785 35 81
E-Mail: tme@dynamicsgroup.ch

Germany:
Christoph Miller
T: +49 (0) 711 947 670
E-Mail: leclanche@sympra.de

Investor contacts:
Hubert Angleys / Pierre Blanc
T: +41 (0) 24 424 65 00
E-Mail: invest.leclanche@leclanche.com

 



End of Media Release


Language: English
Company: Leclanché SA
Av. des Sports 42
1400 Yverdon-les-Bains
Switzerland
Phone: +41 (24) 424 65-00
Fax: +41 (24) 424 65-20
E-mail: investors@leclanche.com
Internet: www.leclanche.com
ISIN: CH0110303119, CH0016271550
Valor: A1CUUB, 812950
Listed: SIX Swiss Exchange
EQS News ID: 2155082

 
End of News EQS News Service

2155082  16.06.2025 CET/CEST

Analysen zu Leclanche (Leclanché SA)

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
Zu diesem Datensatz liegen uns leider keine Daten vor.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Abgestürzte Blue Chip Aktien – Wall Street Live mit Tim Schäfer

Tim Schäfer live aus New York – dieses Mal mit einem spannenden Blick auf abgestürzte Blue-Chip-Aktien, bei denen sich ein Einstieg lohnen könnte. Gemeinsam mit David Kunz analysiert Tim prominente Verlierer der letzten Monate, die möglicherweise vor einer Erholung stehen.

Themen im Video:
🔹 Merck & Co. (USA) – Probleme mit Impfstoffen und Patentlaufzeiten
🔹 Pfizer – Wachstumsdruck durch auslaufende Patente
🔹 United Health – Ermittlungen und steigende Gesundheitskosten
🔹 Novo Nordisk – Abnehmspritze, Wettbewerb und Marktkorrektur
🔹 Nike – Konsumflaute und neue Konkurrenz
🔹 Estée Lauder – Kursabsturz, China-Schwäche und Hoffnung auf Turnaround
🔹 Campbell Soup – Value-Aktie mit attraktiver Dividende
🔹 Regeneron – Erfolgreiche Gründerstory mit Herausforderungen

👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/

Abgestürzte Blue Chip Aktien – Wall Street Live mit Tim Schäfer

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 12’529.65 19.41 BB4SOU
Short 12’777.26 13.83 UEJS6U
Short 13’251.80 8.91 B7ZS2U
SMI-Kurs: 12’033.37 17.06.2025 13:04:45
Long 11’499.81 18.51 BAES3U
Long 11’256.34 13.52 BRTSZU
Long 10’762.58 8.72 BPDSHU
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

finanzen.net News

Datum Titel
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
{{ARTIKEL.NEWS.BODY.TITEL}}